Vitrolife AB (publ) (FRA:VTFN)

Market Cap	1.65B
Revenue (ttm)	317.21M
Net Income (ttm)	39.80M
Shares Out	n/a
EPS (ttm)	0.29
PE Ratio	41.43
Forward PE	60.95
Dividend	0.10 (0.81%)
Ex-Dividend Date	Apr 30, 2025

Volume	n/a
Average Volume	8
Open	12.33
Previous Close	12.34
Day's Range	12.33 - 12.33
52-Week Range	11.28 - 20.78
Beta	n/a
RSI	44.59
Earnings Date	Feb 3, 2026

About Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1989
• Employees: 1,169
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: VTFN

Financial Performance

Financial numbers in SEK